Celebrex Trial Halted After Heart Attacks

Reuters reports that, "A government-sponsored trial of Pfizer Inc.'s blockbuster arthritis drug Celebrex was halted after patients taking the medicine had more than twice as many heart attacks as patients taking a placebo, the company said on Friday."